Additionally, the production of E-, NS1-, or NS5-specific IgG demonstrated that the VSRD-ZIKV-based vaccine induced an immune response against both structural and nonstructural viral proteins, supporting the expression of the entire viral genome through a single-round infection of VSRD-ZIKV in the host (Figure 2B–D). This evidence concerns the gene RAF1 and infection.